Clóvis Arns da Cunha

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Ernst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clóvis Arns da Cunha et al. · The Lancet · 2007 · 689 citations

Invasive Candidosis, Antifungal Agent, Antifungal Agents +8

Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients

A. L. Oliveira, M. de Souza, Viviane Maria Hessel Carvalho-Dias et al. · Bone Marrow Transplantation · 2007 · 168 citations · Full text

Transplantation, Health Sciences, Antimicrobial Susceptibility +10

Brazilian guidelines for the management of candidiasis – a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical

Arnaldo Lopes Colombo, Thaís Guimarães, Luís Fernando Aranha Camargo et al. · The Brazilian Journal of Infectious Diseases · 2013 · 149 citations · Full text

Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil

Sérgio Cimerman, Alberto Chebabo, Clóvis Arns da Cunha et al. · The Brazilian Journal of Infectious Diseases · 2020 · 142 citations · Full text

Virus Epidemiology, Global Health, Global Health Crisis +8

Guidelines for the pharmacological treatment of COVID-19. The task force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology

Maicon Falavigna, Verônica Colpani, Cinara Stein et al. · Revista Brasileira de Terapia Intensiva · 2020 · 120 citations · Full text